You are here

IGF OT IGF SBIR PHASE I TOPIC COMPACT CELL FREE DNA DETECTION ARRAY

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 261201600035C-0-0-0
Agency Tracking Number: N43CA160035
Amount: $299,999.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: NCI
Solicitation Number: N/A
Timeline
Solicitation Year: 2016
Award Year: 2016
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
6201 E. OLTORF
AUSTIN, TX 78741-7510
United States
DUNS: 100651798
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 ALEXIS HUDAK
 (512) 389-9990
 mmayo@nanohmics.com
Business Contact
 ALEXIS HUDAK
Phone: (512) 389-9990
Email: mmayo@nanohmics.com
Research Institution
N/A
Abstract

Cell free nucleic acid cfNA biomarkers circulating in the blood have the potential to serve as simple rapid and non invasive diagnostic indicators As such cell free biomarkers have emerged in the forefront of cancer diagnostic research with the promise of improved disease state prognostication therapy resistance monitoring and metastasis or recurrence determination using a simple blood test A multiplexed cancer diagnostic device with the sensitivity to detect low molecular copies of biomarkers of specific cancer genotypes simplicity of blood plasma lateral flow strip assays and robustness of nucleic acid microarrays that can be packaged as a comprehensive genotype cancer diagnostic panel would greatly improve early detection rates of recurrence and metastasis and guide the oncology treatment plan To overcome barriers limiting the adoption of high density microassays in diagnostic settings Arrion Sciences an early stage biotechnology and sensor development subsidiary Austin TX working in collaboration with LC Sciences Houston TX DRS Technologies the University of Texas at Austin Microelectronics Research Center UT MRC and Dr Sylvie Beaudenon Huibregste is proposing to develop a multiplexed biodetection array platform with nucleic acid probes for detection of clinically significant cell free breast cancer biomarkers in the blood

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government